Biologicals Are Booming, Yet 38.5% of the Market Still Doesn't Trust Them
Sales are soaring, investments are pouring in, and adoption continues to expand. Yet nearly four out of ten agricultural professionals still question the effectiveness of biological products.
Biological products are gaining ground across farms worldwide, attracting billions of dollars in investment and positioning themselves as a key pillar of the future of agriculture. Yet behind the growth lies a troubling reality: 38.5% of the market still is not convinced these products deliver on their promises.
The finding emerges from an industry-wide survey of agricultural retailers, consultants, distributors, and crop advisors, highlighting a challenge that continues to slow broader adoption despite strong market momentum.
The number is particularly striking because it comes at a time when the biologicals industry is experiencing unprecedented expansion. The global biologicals market is now valued at approximately $17 billion, while revenues in the United States alone exceeded $3.5 billion in 2025.
Despite this rapid growth, a significant portion of the agricultural sector continues to demand stronger agronomic evidence, independent validation, and more consistent field performance before fully embracing biological solutions.
The Surprising Data: Lack of Trust Outweighs Cost Concerns
Analysis of the survey results shows that the primary barrier to biological adoption is neither pricing nor regulation.
Top Barriers to Biological Adoption
| Factor | Share of Responses | Market Impact |
|---|---|---|
| Lack of confidence in product performance | 38.5% | Largest obstacle to adoption |
| High costs | 19% | Limits perceived ROI |
| Belief that conventional products work better | 16% | Preserves traditional product preference |
Trust remains the single biggest obstacle to market expansion, ranking well above concerns about cost or competition from conventional crop inputs.
According to industry experts, many growers still want additional field trials, independent research, and side-by-side comparisons that clearly demonstrate economic return and agronomic value.
The findings also reflect a broader shift in grower expectations. Sustainability claims and innovative technologies alone are no longer enough.
Today's producers increasingly demand hard data, repeatable results, and measurable economic outcomes before changing established crop management practices.
A Multi-Billion-Dollar Industry Still Seeking Validation
Despite ongoing skepticism, the growth trajectory for biological products remains strong.
Biostimulants account for 50% of all biological sales, making them the dominant category in the sector. They are followed by biofertilizers at 32% and biopesticides at 18%.
Biological Market Share by Segment
| Segment | Market Share | Trend |
| Biostimulants | 50% | Market leader |
| Biofertilizers | 32% | Stable growth |
| Biopesticides | 18% | Gradual expansion |
Several factors continue driving adoption, including the growth of regenerative agriculture, increasing demand for nutrient-use efficiency, sustainability initiatives, and efforts to improve long-term soil health.
Yet industry observers agree that the challenge facing biologicals is no longer technological.
The challenge is credibility.
As a result, manufacturers, distributors, and agricultural organizations are investing heavily in product validation programs, certification initiatives, independent trials, and scientific research designed to strengthen grower confidence.
The sector is entering a new phase of maturity, where success will depend less on innovation alone and more on proving value acre by acre.
More Investment, More Adoption, and One Critical Battle Ahead
The outlook for biologicals remains overwhelmingly positive. Most distributors expect to expand their biological product portfolios in the coming years, while major agricultural companies continue increasing investments in research and development.
However, long-term growth will ultimately depend on addressing one fundamental issue:
Turning technological promise into grower confidence.
Biologicals have already evolved from a niche category into a multi-billion-dollar agricultural market. Yet for nearly four out of every ten industry professionals, the industry still has work to do before biological products earn the same level of trust as conventional crop inputs.
That battle for credibility may ultimately determine how quickly biologicals become a mainstream tool in modern agriculture.
